[{"id":"995d7ed3-58bc-4c2b-813c-b6a4de641715","acronym":"CRUKD14/001","url":"https://clinicaltrials.gov/study/NCT02546921","created_at":"2022-05-26T00:57:40.094Z","updated_at":"2024-07-02T16:35:46.536Z","phase":"Phase 1","brief_title":"Phase I Study of MOv18 IgE","source_id_and_acronym":"NCT02546921 - CRUKD14/001","lead_sponsor":"Cancer Research UK","biomarkers":" MUC16","pipe":" | ","alterations":" MUC16 elevation","tags":["MUC16"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MUC16 elevation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MOv18 IgE"],"overall_status":"Completed","enrollment":" Enrollment 26","initiation":"Initiation: 02/16/2016","start_date":" 02/16/2016","primary_txt":" Primary completion: 06/22/2021","primary_completion_date":" 06/22/2021","study_txt":" Completion: 07/30/2021","study_completion_date":" 07/30/2021","last_update_posted":"2023-06-05"}]